Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Stryker (NYSE:SYK) makes good on a promise to cut jobs ahead of the 2.3 percent med-tech tax by shuttering two New York plants, leaving 160 out of work.
Sanofi’s iPhone glucose meter, the iBGStar, landed 510(k) clearance from the FDA, making it the first iPhone glucose meter to win a nod from the federal watchdog agency.
CardioMEMS CEO Jay Yadav comments on the FDA ruling that failed to confirm that the benefits outweigh the risks of a his company’s implantable heart pressure monitor. The ruling cast a shadow on St. Jude Medical’s potential $375 million buyout.